X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
adult (4) 4
female (4) 4
index medicus (4) 4
male (4) 4
middle aged (4) 4
aged (3) 3
hematology (3) 3
neoplasm staging (3) 3
young adult (3) 3
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
combined modality therapy (2) 2
lymphomas (2) 2
oncology (2) 2
retrospective studies (2) 2
survival analysis (2) 2
transplantation (2) 2
abdomen (1) 1
adolescent (1) 1
aged, 80 and over (1) 1
analysis (1) 1
anthracycline (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic antibiotics (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apple macintosh (1) 1
article (1) 1
b-cell lymphoma (1) 1
biopsy (1) 1
bleomycin (1) 1
bleomycin - administration & dosage (1) 1
blood (1) 1
bone marrow (1) 1
brentuximab (1) 1
brentuximab vedotin (1) 1
brentuximab vedotin, relapsed systemic anaplastic large cell lymphoma (1) 1
cancer (1) 1
cancer research (1) 1
care and treatment (1) 1
cell survival (1) 1
chemotherapy (1) 1
chemotherapy plus rituximab (1) 1
chest (1) 1
chop-like chemotherapy (1) 1
clinical trials (1) 1
complications and side effects (1) 1
computed tomography (1) 1
computer science, interdisciplinary applications (1) 1
computer systems (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
data interpretation, statistical (1) 1
database (1) 1
diaphragm (1) 1
disease spread (1) 1
disease-free survival (1) 1
dose-response relationship, drug (1) 1
doxorubicin (1) 1
doxorubicin - administration & dosage (1) 1
drug administration schedule (1) 1
drug resistance, neoplasm (1) 1
ethics (1) 1
follow-up studies (1) 1
genetics (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation (1) 1
high-dose therapy (1) 1
immunoconjugates - administration & dosage (1) 1
immunoconjugates - adverse effects (1) 1
immunoconjugates - therapeutic use (1) 1
immunotherapy (1) 1
international workshop (1) 1
involved-field radiotherapy (1) 1
italy (1) 1
kaplan-meier estimate (1) 1
kidney graft outcome (1) 1
kidney transplantation (1) 1
kidney transplantation - mortality (1) 1
leucovorin (1) 1
leucovorin - administration & dosage (1) 1
lymphocytes b (1) 1
lymphoma (1) 1
lymphoma, follicular - mortality (1) 1
lymphoma, follicular - pathology (1) 1
lymphoma, follicular - therapy (1) 1
lymphoma, large b-cell, diffuse (1) 1
lymphoma, large b-cell, diffuse - drug therapy (1) 1
lymphoma, large b-cell, diffuse - pathology (1) 1
lymphoma, large b-cell, diffuse - radiotherapy (1) 1
lymphoma, large b-cell, diffuse - therapy (1) 1
lymphoma, large-cell, anaplastic - drug therapy (1) 1
lymphoma, large-cell, anaplastic - mortality (1) 1
lymphoma, large-cell, anaplastic - pathology (1) 1
lymphoma, non-hodgkin - mortality (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 4, pp. 352 - 358
Journal Article
BMC Cancer, ISSN 1471-2407, 04/2017, Volume 17, Issue 1, pp. 276 - 8
Background: The purpose of this study is to investigate the most suitable first-line approach and the best combination treatment for primary mediastinal large... 
Rituximab | Chemotherapy | Primary mediastinal lymphoma | Radiotherapy | MACOP-B | SINGLE INSTITUTION | primary mediastinal lymphoma | RESPONSE CRITERIA | SCLEROSIS | CHEMOTHERAPY PLUS RITUXIMAB | CHOP-LIKE CHEMOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | INTERNATIONAL WORKSHOP | THERAPY | ONCOLOGY | radiotherapy | INVOLVED-FIELD RADIOTHERAPY | rituximab | Leucovorin - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Young Adult | Rituximab - therapeutic use | Lymphoma, Large B-Cell, Diffuse - therapy | Mediastinal Neoplasms - drug therapy | Mediastinal Neoplasms - therapy | Immunotherapy | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Bleomycin - administration & dosage | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Mediastinal Neoplasms - radiotherapy | Adolescent | Methotrexate - administration & dosage | Aged | Neoplasm Staging | Complications and side effects | Care and treatment | Usage | Lymphomas | Cancer
Journal Article
Haematologica, ISSN 0390-6078, 10/2017, Volume 102, Issue 11, pp. 1931 - 1935
Journal Article
M.D. Computing, ISSN 0724-6811, 1991, Volume 8, Issue 3, pp. 172 - 177
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.